Chung Kam Run Yin Investment Group
EXBX · OTC
About EXBX
- Employees
- 0
- Headquarters
- Reno, Nevada
- Listed
- Oct 14, 2005
- Sector
- Information Technology
- Industry
- Software
EXBX key statistics
- Market cap
- 398
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 69.61K
- Volume
- 19.89K
- Open price
- $0.00
- High today
- $0.0001
- Low today
- $0.00
- 52 Week high
- $0.0004
- 52 Week low
- $0.00
Chung Kam Run Yin Investment Group (EXBX) at a glance
Chung Kam Run Yin Investment Group (EXBX) last traded at $0.00, with a market cap of 398.
Today the stock has traded between $0.00 and $0.0001. The current price is — above the day's low and 100.0% below its high.
Volume so far is 19.89K shares, below the average of 69.61K shares a day.
Over the past year Chung Kam Run Yin Investment Group has ranged from $0.00 to $0.0004, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as Chung Kam Run Yin Investment Group
Most active stocks
Highest trading volume today
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- WFFWF Holding$0.0929−3.83%
- RCTRedCloud Holdings$0.084+1.94%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- RBNERobin Energy$0.3978−23.65%
- DKIDarkiris$0.0479−6.08%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SOXSDirexion Shares ETF Trust$47.13+1.07%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- NWGLCL Workshop Group$0.1522+27.90%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.